Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194688 · ClinicalTrials.gov registry record · Phase 2
Breath Ammonia Method for H. Pylori Detection: Phase II
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 278
- Enrollment target
NCT00194688 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 278 participants.
The verdict
NCT00194688, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 278 participants
- Enrollment target
Study Summary
The objective is to evaluate the utility of a breath ammonia sensing device. In this study we will assess the effect of H. pylori infection on breath ammonia levels by measuring whether there is a change in the pattern or quantity of breath ammonia seen in H. pylori positive patients compared to H. pylori negative patients.
Interventions
- DRUG H. pylori treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2003-03 |
| Est. Completion | 2005-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00194688
The ClinicalTrials.gov registry entry for NCT00194688 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 278 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which H. pylori treatment is the first listed.
NCT00194688 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00194688 about?
NCT00194688 is a clinical study titled "Breath Ammonia Method for H. Pylori Detection: Phase II". The objective is to evaluate the utility of a breath ammonia sensing device. In this study we will assess the effect of H. pylori infection on breath ammonia levels by measuring whether there is a change in the pattern or quantity of breath ammonia seen in H. pylori positive patients compared to H. ...
What is the current status of trial NCT00194688?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 278 participants. The study started on 2003-03. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00194688?
The interventions under investigation include: H. pylori treatment (DRUG).
Who is sponsoring clinical trial NCT00194688?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.